Health and Fitness Health and Fitness
Tue, January 21, 2025

GLP-1 weight loss drugs linked to a wide range of health benefits and risks: study


Published on 2025-01-21 11:43:12 - MSN
  Print publication without navigation

  • A new peer-reviewed study based on data from nearly 2M individuals highlights a wide range of clinical benefits and risks, including several newly found conditions linked to the GLP-1 class of weight loss and diabetes drugs.

The article from MSN discusses a comprehensive study on GLP-1 weight loss drugs, which are increasingly recognized for their health benefits beyond just weight reduction. These medications, including popular ones like Ozempic and Wegovy, have been linked to a variety of health improvements such as reduced risks of heart disease, stroke, and kidney disease, as well as better control over blood sugar levels in diabetic patients. However, the study also highlights significant risks associated with these drugs, including potential side effects like nausea, vomiting, and more severe issues like pancreatitis, gallbladder disease, and an increased risk of certain cancers. The research emphasizes the need for careful patient selection, monitoring, and management to balance these benefits against the potential adverse effects, suggesting that while GLP-1 agonists offer promising health outcomes, they are not without considerable risks that require medical oversight.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/health/weightloss/glp-1-weight-loss-drugs-linked-to-a-wide-range-of-health-benefits-and-risks-study/ar-AA1xB2of ]
Contributing Sources